ESR2 and neoplasm: The identification of TP53 mutation in the right cerebellar lesion prior to treatment and significant tumor regression after tamoxifen therapy allows for the conclusion of an ERβ-mutant p53-mediated antiproliferative mechanism with reasonable certainty.